[HTML][HTML] COVID-19 and liver disease: mechanistic and clinical perspectives

T Marjot, GJ Webb, AS Barritt IV, AM Moon… - Nature reviews …, 2021 - nature.com
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …

Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

[HTML][HTML] COVID-19 in people with diabetes: understanding the reasons for worse outcomes

M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …

Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] COVID-19 and multiorgan failure: A narrative review on potential mechanisms

T Mokhtari, F Hassani, N Ghaffari, B Ebrahimi… - Journal of molecular …, 2020 - Springer
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2

F Salamanna, M Maglio, MP Landini, M Fini - Frontiers in medicine, 2020 - frontiersin.org
The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

[HTML][HTML] In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19

XJ Zhang, JJ Qin, X Cheng, L Shen, YC Zhao, Y Yuan… - Cell metabolism, 2020 - cell.com
Statins are lipid-lowering therapeutics with favorable anti-inflammatory profiles and have
been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk …

[HTML][HTML] COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge

J Baj, H Karakuła-Juchnowicz, G Teresiński… - Journal of clinical …, 2020 - mdpi.com
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …

Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis

A Bertolini, IP van De Peppel, FAJA Bodewes… - Hepatology, 2020 - journals.lww.com
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …

COVID-19 and sex differences: mechanisms and biomarkers

T Haitao, JV Vermunt, J Abeykoon, R Ghamrawi… - Mayo Clinic …, 2020 - Elsevier
Men are consistently overrepresented in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes …